Scott M. Weishaar


Bates White

Scott Weishaar provides consulting expertise and expert support in complex litigation and government investigations for pharmaceutical manufacturers and wholesalers, pharmacies, healthcare providers, and other life sciences industry participants. These cases often involve economic analysis of class certification, liability, and damages related to federal and state false claims acts (FCA), fraud, and antitrust issues. Mr. Weishaar collaborates with clients to support discovery efforts; provide insights into industry dynamics; manage analysis of large claims, sales, and other industry data; and contribute to case strategy. He has coordinated complex litigation efforts among large client groups, including a group of more than 70 pharmaceutical manufacturers in multistate drug pricing cases and a plaintiff opt-out group in one of the largest price-fixing cases in US history. Mr. Weishaar has worked extensively on healthcare projects involving Medicare and Medicaid, third-party health plans, pharmaceuticals, and medical device manufacturers.